Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 760540, 6 pages
http://dx.doi.org/10.1155/2009/760540
Research Article

Silencing of Tumor Necrosis Factor Receptor 1 by siRNA in EC109 Cells Affects Cell Proliferation and Apoptosis

Department of Histology and Embryology, Medical College of Shantou University, Shantou, Guangdong Province 515041, China

Received 20 February 2009; Revised 16 July 2009; Accepted 23 July 2009

Academic Editor: Phillip Bird

Copyright © 2009 Ma Changhui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Daly, L. H. Karnell, H. R. Menck et al., “National cancer data base report on esophageal carcinoma,” Cancer, vol. 78, no. 8, pp. 1820–1828, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. DeMeester and T. R. DeMeester, “Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy,” Annals of Surgery, vol. 231, no. 3, pp. 303–321, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. W. N. Dinjens, “Genetic alterations in Barrett's esophagus and esophageal adenocarcinoma,” Minerva Chirurgica, vol. 57, no. 6, pp. 733–752, 2002. View at Google Scholar · View at Scopus
  4. L. B. Koppert, B. P. Wijnhoven, H. van Dekken, H. W. Tilanus, and W. N. Dinjens, “The molecular biology of esophageal adenocarcinoma,” Journal of Surgical Oncology, vol. 92, no. 3, pp. 169–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. D. M. Lehrbach, M. E. Nita, and I. Cecconello, “Molecular aspects of esophageal squamous cell carcinoma carcinogenesis,” Arquivos de Gastroenterologia, vol. 40, no. 4, pp. 256–261, 2003. View at Google Scholar · View at Scopus
  6. A. Kyrgidis, J. Kountouras, C. Zavos, and D. Chatzopoulos, “New molecular concepts of Barrett's esophagus: clinical implications and biomarkers,” Journal of Surgical Research, vol. 125, no. 2, pp. 189–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. D. T. McManus, A. Olaru, and S. J. Meltzer, “Biomarkers of esophageal adenocarcinoma and Barrett's esophagus,” Cancer Research, vol. 64, no. 5, pp. 1561–1569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. R. V. Lord, R. O'Grady, C. Sheehan, A. F. Field, and R. L. Ward, “K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction,” Journal of Gastroenterology and Hepatology, vol. 15, no. 7, pp. 730–736, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Güner, I. Sturm, P. Hemmati et al., “Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis,” International Journal of Cancer, vol. 103, no. 4, pp. 445–454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-K. Gerber, T. Richter, E. Kremmer et al., “Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus,” Journal of Pathology, vol. 197, no. 3, pp. 293–297, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Vandenabeele, W. Declerq, R. Beyaert, and W. Fiers, “Two tumour necrosis factor receptors: structure and function,” Trends in Cell Biology, vol. 5, no. 10, pp. 392–399, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. MacEwan, “TNF ligands and receptors—a matter of life and death,” British Journal of Pharmacology, vol. 135, no. 4, pp. 855–875, 2002. View at Google Scholar · View at Scopus
  13. J. R. Muppidi, J. Tschopp, and R. M. Siegel, “Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction,” Immunity, vol. 21, no. 4, pp. 461–465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Elbashir, W. Lendeckel, and T. Tuschl, “RNA interference is mediated by 21- and 22-nucleotide RNAs,” Genes & Development, vol. 15, no. 2, pp. 188–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Berns, E. M. Hijmans, J. Mullenders et al., “A large-scale RNAi screen in human cells identifies new components of the p53 pathway,” Nature, vol. 428, no. 6981, pp. 431–437, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Saito, H. Yokota, Y. Sudo, Y. Yakabe, H. Takeyama, and T. Matsunaga, “Application of RNAi inducible TNFRI knockdown cells to the analysis of TNF-alpha-induced cytotoxicity,” Toxicology in Vitro, vol. 20, no. 8, pp. 1343–1353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Guo, S. Chen, J. Zhang et al., “Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood,” Vaccine, vol. 23, no. 45, pp. 5225–5230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y.-Z. Deng, P.-P. Chen, Y. Wang et al., “Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling,” Journal of Biological Chemistry, vol. 282, no. 50, pp. 36571–36581, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Aigner, “Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo,” Applied Microbiology and Biotechnology, vol. 76, no. 1, pp. 9–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Song, S. Guha, K. Liu, N. S. Buttar, and R. S. Bresalier, “COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma,” Gut, vol. 56, no. 11, pp. 1512–1521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Tanaka, Y. Hashimoto, T. Ito et al., “The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma,” Clinical Cancer Research, vol. 13, no. 4, pp. 1331–1340, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. N. S. Wilson, V. Dixit, and A. Ashkenazi, “Death receptor signal transducers: nodes of coordination in immune signaling networks,” Nature Immunology, vol. 10, no. 4, pp. 348–355, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. N. L. Malinin, M. P. Boldin, A. V. Kovalenko, and D. Wallach, “MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1,” Nature, vol. 385, no. 6616, pp. 540–544, 1997. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Tian, W.-D. Zang, W.-H. Hou, H.-T. Liu, and L.-X. Xue, “Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA,” Acta Biochimica et Biophysica Sinica, vol. 38, no. 5, pp. 318–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore, “Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB,” Nature, vol. 376, no. 6536, pp. 167–170, 1995. View at Google Scholar · View at Scopus
  26. C.-Y. Wang, J. C. Cusack Jr., R. Liu, and A. S. Baldwin Jr., “Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB,” Nature Medicine, vol. 5, no. 4, pp. 412–417, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. J. R. Meng, N. Zhao, Z. Yan et al., “Expression of TNFRs in tumor cells and effect of novel rhTNF on tumor cell growth,” China Journal of Cellular & Molecular Immunology, vol. 18, no. 5, pp. 10–12, 2002. View at Google Scholar